Biomerica is a global biomedical technology company that develops, manufactures, and markets diagnostic test kits used in clinical laboratories and point-of-care settings to detect diseases, food intolerances, and medical conditions by analyzing blood, urine, nasal, or fecal samples. The company's primary offerings include inFoods IBS, a proprietary blood test that identifies patient-specific food triggers for irritable bowel syndrome symptoms, and hp+detect, an FDA-cleared test for detecting Helicobacter pylori bacteria; the company also sells legacy rapid diagnostic tests for home and point-of-care use. Biomerica generates revenue by selling diagnostic products through a network of independent distributors across multiple countries and direct sales channels to hospitals, clinical laboratories, physicians' offices, and other healthcare providers, while pursuing insurance reimbursement and exploring partnerships with larger life sciences companies to expand market reach.